• Title of article

    Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality

  • Author/Authors

    Marc-André Mouthon، نويسنده , , Marie-Hélène Gaugler، نويسنده , , Anne Van der Meeren، نويسنده , , Marie Vandamme، نويسنده , , Patrick Gourmelon، نويسنده , , Gerard Wagemaker، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2001
  • Pages
    11
  • From page
    30
  • To page
    40
  • Abstract
    Objective A sufficiently high dose of thrombopoietin to overcome initial c-mpl–mediated clearance stimulates hematopoietic reconstitution following myelosuppressive treatment. We studied the efficacy of thrombopoietin on survival after supralethal total body irradiation (9 Gy) of C57BL6/J mice and the occurrence of infectious and thrombotic complications in comparison with a bone marrow graft or prophylactic antibiotic treatment. Methods and Results Administration of 0.3 μg thrombopoietin, 2 hours after irradiation, protected 62% of the mice as opposed to no survival in placebo controls. A graft with a supraoptimal number of syngeneic bone marrow cells (106 cells) fully prevented mortality, whereas antibiotic treatment was ineffective. Blood cell recovery was observed in the thrombopoietin-treated mice but not in the placebo or antibiotic-treated group. Bone marrow and spleen cellularity as well as colony-forming unit granulocyte-macrophage and burst-forming unit erythroid were considerably increased in thrombopoietin-treated mice relative to controls. Histologic examination at day 11 revealed numerous petechiae and vascular obstructions within the brain microvasculature of placebo-treated mice, which was correlated with hypercoagulation and hypofibrinolysis. Thrombopoietin treatment prevented coagulation/fibrinolysis disorder and vascular thrombosis. High fibrinogen levels were related to bacterial infections in 67% of placebo-treated mice and predicted mortality, whereas the majority of the thrombopoietin-treated mice did not show high fibrinogen levels and endotoxin was not detectable in plasma. Conclusion We conclude that thrombopoietin administration prevents mortality in mice subjected to 9-Gy total body irradiation both by interfering in the cascade leading to thrombotic complications and by amelioration of neutrophil and platelet recovery and thus protects against infections and hemorrhages.
  • Keywords
    Thrombopoietin , irradiation , infection , thrombosis , Hematopoiesis
  • Journal title
    Experimental Hematology
  • Serial Year
    2001
  • Journal title
    Experimental Hematology
  • Record number

    513454